World's Best Scientists 2026 revealed!
José L. Lanciego

José L. Lanciego

D-Index & Metrics

Neuroscience

D-Index
60
Citations
11031
World Ranking
3886
National Ranking
53

Overview

José L. Lanciego is affiliated with the University of Navarra in Spain. Their research spans several areas within the life sciences, with significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Medicine, and Neuroscience. Their work particularly focuses on Molecular Biology, Neurology, Cellular and Molecular Neuroscience, Genetics, and Physiology.

The primary research topics addressed by José L. Lanciego include Parkinson's Disease Mechanisms and Treatments, Neuroscience and Neuropharmacology Research, Neurological Disorders and Treatments, RNA Regulation and Disease, Virus-based Gene Therapy Research, Nerve Injury and Regeneration, and Porphyrin Metabolism and Disorders.

Among the recent publications authored or co-authored by José L. Lanciego are:

  • Neuroanatomical tract-tracing techniques that did go viral (2020, Brain Structure and Function)
  • Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration (2021, Acta Neuropathologica Communications)
  • Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques (2021, International Journal of Molecular Sciences)
  • An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria (2021, Redox Biology)
  • Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates (2020, Brain Structure and Function)

José L. Lanciego frequently collaborates with a group of co-authors who have contributed extensively alongside them. Notable frequent co-authors include Alberto J. Rico, Elvira Roda, Julia Chocarro, Goiaz Ariznabarreta, and Adriana Honrubia.

Their research has appeared repeatedly in several publication venues, including bioRxiv (Cold Spring Harbor Laboratory), Zenodo (CERN European Organization for Nuclear Research), Brain Structure and Function, International Journal of Molecular Sciences, and Neurobiology of Disease.

The scope of José L. Lanciego's work encompasses both foundational and applied aspects of neuroscience and molecular biology, with a particular emphasis on conditions related to neurodegeneration and neurological disorders. Their research outputs contribute to understanding molecular mechanisms, therapeutic approaches, and experimental methodologies relevant to these fields.

Best Publications

  • Pathophysiology of the basal ganglia in Parkinson's disease.

    José A. Obeso;Maria C. Rodriguez-Oroz;Manuel Rodriguez;José L. Lanciego

  • Functional Neuroanatomy of the Basal Ganglia

    José L. Lanciego;Natasha Luquin;José A. Obeso

  • Current concepts in neuroanatomical tracing

    C. Köbbert;R. Apps;I. Bechmann;J.L. Lanciego

  • Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.

    Lucía Callén;Lucía Callén;Estefanía Moreno;Estefanía Moreno;Pedro Barroso-Chinea;David Moreno-Delgado;David Moreno-Delgado

  • A half century of experimental neuroanatomical tracing.

    José L. Lanciego;Floris G. Wouterlood

  • Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.

    Jose L. Labandeira-Garcia;Ana I. Rodríguez-Perez;Pablo Garrido-Gil;Jannette Rodriguez-Pallares

  • Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

    Marie Therese Armentero;Annalisa Pinna;Sergi Ferré;José Luis Lanciego

  • The origin of motor fluctuations in Parkinson’s disease: Importance of dopaminergic innervation and basal ganglia circuits

    J. A. Obeso;M. Rodriguez-Oroz;C. Marin;F. Alonso

  • Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD.

    Carolina García-Barroso;Ana Ricobaraza;María Pascual-Lucas;Nora Unceta

  • Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

    Eva Martínez-Pinilla;Katia Varani;Irene Reyes-Resina;Edgar Angelats;Edgar Angelats

  • Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.

    E. Garbayo;C.N. Montero-Menei;E. Ansorena;J.L. Lanciego

  • Expression of the mRNAs encoding for the vesicular glutamate transporters 1 and 2 in the rat thalamus.

    Pedro Barroso-Chinea;María Castle;María S. Aymerich;Mónica Pérez-Manso

  • Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis.

    José L Lanciego;José L Lanciego;Pedro Barroso-Chinea;Pedro Barroso-Chinea;Alberto J Rico;Alberto J Rico;Lorena Conte-Perales;Lorena Conte-Perales

  • Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization.

    Rafael Franco;Eva Martínez-Pinilla;José L. Lanciego;Gemma Navarro

  • Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia

    Gemma Navarro;Dasiel Borroto-Escuela;Edgar Angelats;Íñigo Etayo

  • Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin–angiotensin system in the nigra

    Pablo Garrido-Gil;Rita Valenzuela;Begoña Villar-Cheda;Jose L. Lanciego

  • AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy.

    Giuseppe Morabito;Serena G. Giannelli;Gabriele Ordazzo;Simone Bido

  • Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

    Rita Valenzuela;Maria A Costa-Besada;Javier Iglesias-Gonzalez;Emma Perez-Costas

  • Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine.

    Fabio Blandini;Roberto Cilia;Silvia Cerri;Gianni Pezzoli

  • Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism.

    Salvador Sierra;Natasha Luquin;Alberto J Rico;Virginia Gómez-Bautista

  • Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi- and contralateral projections.

    Maria Castle;Maria S Aymerich;Carlos Sanchez-Escobar;Nancy Gonzalo

Frequent Co-Authors

Jose L. Labandeira-Garcia
Jose L. Labandeira-Garcia University of Santiago de Compostela
Gemma Navarro
Gemma Navarro University of Barcelona
Floris G. Wouterlood
Floris G. Wouterlood Vrije Universiteit Amsterdam
Annalisa Pinna
Annalisa Pinna National Research Council (CNR)
Sergi Ferré
Sergi Ferré National Institute on Drug Abuse
Maria J. Guerra
Maria J. Guerra University of Santiago de Compostela
Gabriel Rubio
Gabriel Rubio Complutense University of Madrid
Laszlo Zaborszky
Laszlo Zaborszky Rutgers, The State University of New Jersey
Andrew L. Gundlach
Andrew L. Gundlach Florey Institute of Neuroscience and Mental Health
Manuel Rodriguez
Manuel Rodriguez University of La Laguna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing José L. Lanciego

Trending Scientists